NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

“It seems more and more clear that NWBO never intended to submit the DCVax-L trial results to the FDA”

— 1000%. FDA has pretty much indicated that the phase 3 data and ECA will not fly under the current regulations. Thats why Dr Musella has been trying to get the new pathway act passed. Again, NWBO has withheld this info from shareholders! Otherwise any serious company would have applied to the world’s biggest and most lucrative market in less than 5 years from data lock regardless of how big or small the company is (as long as the data is semi decent!).

Also, NWBO indicated earlier this year including the last report that they are looking at striking manufacturing contract in the US for their in-licensed Roswell tech rather than their own DCVAX-L. Tells you that DCVAX-L is not in their commercial plans for the US.